| 000 | 01775 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515125742.0 | ||
| 264 | 0 | _c20081014 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1600-0609 | ||
| 024 | 7 |
_a10.1111/j.1600-0609.2008.01113.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPennanen, Heli | |
| 245 | 0 | 0 |
_aPrognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology _cOct 2008 |
||
| 300 |
_a289-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Leukemic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunochemistry |
| 650 | 0 | 4 |
_aLymph Nodes _xmetabolism |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xbiosynthesis |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xbiosynthesis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xbiosynthesis |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-2 _xbiosynthesis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xbiosynthesis |
| 700 | 1 | _aKuittinen, Outi | |
| 700 | 1 | _aSoini, Ylermi | |
| 700 | 1 | _aTurpeenniemi-Hujanen, Taina | |
| 773 | 0 |
_tEuropean journal of haematology _gvol. 81 _gno. 4 _gp. 289-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.2008.01113.x _zAvailable from publisher's website |
| 999 |
_c18097954 _d18097954 |
||